ATEN vs CXM

The Advanced Deterministic Scorecard reveals a mixed financial profile for ATEN, with a Piotroski F-Score of 4/9 indicating borderline financial health and no available Altman Z-Score to assess bankruptcy risk. Despite solid profitability metrics—such as a 79.66% gross margin, 23.88% ROE, and consistent earnings surprises—the stock trades at a premium valuation (P/E 25.19 vs. sector avg 87.63) while exhibiting weak earnings growth (YoY -0.30%) and bearish insider activity. The current price of $17.38 is significantly above both the Graham Number ($6.68) and intrinsic value estimate ($4.83), suggesting overvaluation unless growth accelerates. Technical trend is bearish, and recent price performance has underperformed over the past year (-9.5%), offsetting strong long-term earnings execution and sector-relative resilience.

CXM exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9 and no Altman Z-Score provided. Despite consistent earnings beats and a clean balance sheet (Debt/Equity 0.08), the stock is trading at a significant premium to its Graham Number ($2.20) and Intrinsic Value ($0.63). Severe price erosion across all timeframes, combined with aggressive insider selling and a -90% YoY earnings collapse, outweighs the optimistic forward P/E and PEG ratio.